Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
-
- Christine Dierks
- Department of Hematology and Oncology, KIM IV, Faculty of Medicine, University Halle-Wittenberg, Halle, Germany.
-
- Jochen Seufert
- Division of Endocrinology and Diabetology, Department of Medicine II, University of Freiburg, Freiburg, Germany.
-
- Konrad Aumann
- Institute of Pathology, University of Freiburg, Germany.
-
- Juri Ruf
- Department of Nuclear Medicine, University of Freiburg, Germany.
-
- Claudius Klein
- Department of Hematology and Oncology, University of Freiburg, Freiburg, Germany.
-
- Selina Kiefer
- Institute of Pathology, University of Freiburg, Germany.
-
- Michael Rassner
- Department of Hematology and Oncology, University of Freiburg, Freiburg, Germany.
-
- Melanie Boerries
- German Cancer Research Center (DKFZ), Heidelberg, Germany.
-
- Andreas Zielke
- Outcomes Research Unit, Department of Endocrine Surgery, Endocrine Center Stuttgart, Diakonie Klinikum Stuttgart, Stuttgart, Germany.
-
- Paul la Rosee
- Klinikum Villingen-Schwenningen, Hämatologie/Onkologie, Villingen-Schwenningen, Germany.
-
- Philipp Tobias Meyer
- Department of Nuclear Medicine, University of Freiburg, Germany.
-
- Matthias Kroiss
- Division of Endocrinology/Diabetology, Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany.
-
- Christian Weißenberger
- Zentrum für Strahlentherapie, Freiburg, Germany.
-
- Tilmann Schumacher
- Praxis für Nuklearmedizin, Freiburg, Germany.
-
- Patrick Metzger
- Institute of Medical Bioinformatics and Systems Medicine and Institute of Molecular Medicine and Cell Research; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
-
- Harald Weiss
- Eisai GmbH, Frankfurt/Main, Germany.
-
- Constantin Smaxwil
- Outcomes Research Unit, Department of Endocrine Surgery, Endocrine Center Stuttgart, Diakonie Klinikum Stuttgart, Stuttgart, Germany.
-
- Katharina Laubner
- Division of Endocrinology and Diabetology, Department of Medicine II, University of Freiburg, Freiburg, Germany.
-
- Justus Duyster
- Department of Hematology and Oncology, University of Freiburg, Freiburg, Germany.
-
- Nikolas von Bubnoff
- Department of Hematology and Oncology, University of Freiburg, Freiburg, Germany.
-
- Cornelius Miething
- Department of Hematology and Oncology, University of Freiburg, Freiburg, Germany.
-
- Oliver Thomusch
- Department of General and Visceral Surgery, University Hospital Freiburg, Freiburg, Germany.
収録刊行物
-
- Thyroid
-
Thyroid 31 (7), 1076-1085, 2021-07-01
Mary Ann Liebert Inc